Probiotics in the Treatment of Irritable Bowel Syndrome

Last updated: April 18, 2013
Sponsor: Islamic Azad University, Najafabad Branch
Overall Status: Completed

Phase

2/3

Condition

Gastrointestinal Diseases And Disorders

Lactose Intolerance

Colic

Treatment

N/A

Clinical Study ID

NCT01837485
15010101882058
  • Ages 18-65
  • All Genders

Study Summary

Some evidences have shown that probiotics are effective in the treatment of irritable bowel syndrome. Because few evidences are available in our population, we investigated if probiotics are effective in our patients as well. We hypothesize that the probiotic Lactol which contains Lactobacillus Sporogenes reduces the symptoms of irritable bowel syndrome.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age between 18 and 65

  • diagnosis of IBS based on the Rome III criteria

  • willingness to participate

Exclusion

Exclusion Criteria:

  • receiving other probiotics compound during the study

  • receiving antibiotics during the study

Study Design

Total Participants: 82
Study Start date:
August 01, 2011
Estimated Completion Date:
March 31, 2013

Connect with a study center

  • Shariati Hospital

    Isfahan,
    Iran, Islamic Republic of

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.